Playback speed
10 seconds
PD-L1 CPS As a Biomarker for Patient Selection for Immunotherapy in Advanced Esophagogastric Adenocarcinoma
By
Cedars Sinai
FEATURING
Jun Gong
By
Cedars Sinai
FEATURING
Jun Gong
260 views
May 13, 2022
Comments 0
Login to view comments.
Click here to Login
Related Videos
AUTOPLAY